Notice of Interim Results

Summary by AI ^BETAClose X

Fevara plc, an international specialist in livestock supplements, has announced that its interim results for the six months ended 28 February 2026 will be released on Wednesday, 22 April 2026. This announcement is crucial for investors as it will provide key financial performance data for the first half of the fiscal year, which could influence the company's stock share price.

Disclaimer*

Fevara PLC

02 April 2026

2 April 2026

Fevara plc

("Fevara" or the "Group")

Notice of Interim Results

Fevara plc (LSE: FVA), an international specialist in livestock supplements, will announce its results for the six months ended 28 February 2026 on Wednesday 22 April 2026.

For further information, please contact:

Enquiries


Fevara plc	+44 (0) 1228 554 600
Joshua Hoopes, Chief Executive Officer Gavin Manson, Chief Financial Officer
Hudson Sandler	+44 (0) 20 7796 4133
Hattie Dreyfus / Nick Moore / Francesca Rosser

About Fevara plc:

Fevara is an international specialist in livestock supplements.

Fevara's purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture. The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including Crystalyx®, Horslic®, Horslyx®, Scotmin Nutrition®, SmartLic®, Tracesure® Advanced and Macal®.

Headquartered in Carlisle, Cumbria, in the UK, Fevara has six manufacturing sites in the UK, US and Brazil with three operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.

Fevara has been listed on the London Stock Exchange since 1972.

For more information, visit: www.fevara.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END